for

Simple to Join, Hard to Miss – HTX Launches “Earn as You Borrow” Week for Traders to Capture Market Opportunities at Lower Cost

PANAMA CITY, Nov. 10, 2025 /PRNewswire/ -- HTX today announced the launch of "Earn as You Borrow" Week, a limited-time…

3 months ago

Redington Foundation joins hands with Protean VidyaSaarthi for 1 Crore+ Scholarship Program

₹ 1 crore+ commitment to fund education for 600+ students across India Renewal scholarships to ensure continuity from school to…

3 months ago

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

Multicenter outcomes FISH&CHIPS study of nearly 8,000 patients confirms total plaque volume as a powerful independent predictor of long-term cardiovascular…

3 months ago

George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Associations Scientific Sessions 2025

London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs…

3 months ago

Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025

November 09, 2025 09:00 ET  | Source: Medera Inc. BOSTON, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a…

3 months ago

Louis Limited Sets New Standard for Trading Psychology With Dynamic Emotion Tracking Features

Louis Limited sets a new benchmark in trading psychology with a feature-rich platform that combines real-time emotion tracking, behavioral analytics,…

3 months ago

AI Meets Digital Assets: CreditBlockchain Launches Free Cloud Trial for XRP Investors Era

New York, NY, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Credit Blockchain, a global fintech company pioneering AI-driven digital finance, today…

3 months ago

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

November 08, 2025 11:45 ET  | Source: Vor Biopharma Treatment with telitacicept for 39 weeks resulted in a rapid, clinically…

3 months ago

Riyadh Opens Its Doors to the World: Biban 2025 Kicks Off as the Global Destination for Opportunities

RIYADH, Saudi Arabia, Nov. 6, 2025 /PRNewswire/ -- The Small and Medium Enterprises General Authority (Monsha'at) in Saudi Arabia inaugurated…

3 months ago

Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy

Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase 3 trial met its primary endpoint at the…

3 months ago